
20 Sep 2023
Oxford Biomedica: Is more capacity the answer after a 33% decline in H1 sales?
This content is only available within our institutional offering.

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Oxford Biomedica: Is more capacity the answer after a 33% decline in H1 sales?
Oxford BioMedica plc (OXB:LON) | 631 -37.9 (-0.9%) | Mkt Cap: 758.5m
- Published:
20 Sep 2023 -
Author:
Paul Cuddon | Kane Slutzkin -
Pages:
4 -